Regulation & Compliance

ICON plc opens a state-of-the-art San Antonio research unit, aiming to accelerate drug development and improve the patient trial experience.

A new campaign is challenging perceptions of Alzheimer's, but it's fueled by more than stories. It's a nexus of new drugs, blood tests, and patient advocacy.

A new partnership aims to industrialize AI development for enterprises, promising tangible cost savings and a blueprint for the future engineering workforce.

The new tool promises to transform customer service by providing real-time AI assistance, boosting agent performance in an increasingly complex support landscape.

A new startup offers Missourians an instant 10% cut on medical bills. But can its model fix a broken system? Here's how it plans to tackle patient debt.

A new price feed for real-world assets like gold and Tesla promises continuous trading, challenging the 9-to-5 financial world and wooing institutions.

South Jersey Industries offers to buy back $287.5M in notes for just 9 cents on the dollar, forcing a tough choice on bondholders. What's behind the move?

A new national survey reveals a crisis of trust in the American workplace, with widespread fear silencing employees and ethical pressures on the rise.

Plaud's new AI platform, Plaud Team, moves beyond note-taking to create a shared intelligence layer from meetings, calls, and in-person discussions.

A new strategic alliance brings European cGMP-grade vitamin APIs to the U.S., promising to enhance quality and supply reliability for compounding pharmacies.

As the DEA moves to reschedule cannabis, banks like TASI navigate a complex legal gray area, highlighting the urgent need for federal banking reform.

University Hospitals pioneers a new era of patient safety by integrating supplement recommendations directly into its electronic health records.

A new partnership provides sexual assault survivors with private, lab-accurate STI tests they can use at home, getting results in 30 minutes.

As residential solar booms, thousands of homeowners are trapped by misleading contracts and broken promises, sparking a surge in consumer advocacy.

Two neurotech giants are creating an open ecosystem for AI in brain imaging, aiming to speed up diagnostics for epilepsy, tumors, and brain injury.

As data breach litigation skyrockets, specialist law firm Mullen Coughlin bolsters its defense with the strategic hire of 30-year trial veteran MaryEllen Conroy.

A new report reveals that equipment fires, regulatory hurdles, and subtle operational flaws are emerging as major threats to the clean energy transition.

A new report charts a course for embedding AI into core workflows, aiming to ease clinician burnout and improve care without sacrificing human oversight.

A new yeast-based tech cuts juice sugar by 30% naturally, just as new EU rules create a market. AUSTRIA JUICE aims to change the breakfast game.

With demand for blood and plasma soaring, Canadian Blood Services is betting on national pride to solve a critical shortage. But can a new campaign work?